Coagulopathy

Published on 26/03/2015 by admin

Filed under Critical Care Medicine

Last modified 26/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1359 times

21 Coagulopathy

Hemostasis is a dynamic and highly complex process typically divided into two components: primary and secondary. Primary hemostasis refers to the blood vessel and platelet response, whereas secondary hemostasis refers to the protein response (clotting cascade). In reality, both primary and secondary hemostasis are tightly interconnected, feed back on each other, and operate in unison. Nevertheless, from a conceptual standpoint, it is helpful to consider each limb of hemostasis separately. In this chapter, we review the clotting mechanism. The reader is referred to Chapter 20 for a discussion of the most common coagulation disorder in the ICU: thrombocytopenia.

image General Principles

The blood clotting cascade is highly complex, consisting of a series of linked reactions. In each reaction, a serine protease, once activated, is capable of activating its downstream substrate. For the purposes of this chapter, the scheme will be simplified according to the following themes: (1) the final step in the clotting cascade is the conversion of fibrinogen to fibrin, a process mediated by thrombin; (2) fibrin is the “glue” that holds platelet plugs together and contributes to the host defense against pathogens; (3) there are two pathways—extrinsic and intrinsic—that converge to induce thrombin generation and fibrin formation; (4) blood coagulation is always initiated by the extrinsic pathway (via tissue factor) and amplified by the intrinsic pathway; (5) the prothrombin time (PT) measures the integrity of the extrinsic (and common) pathways, and the activated partial thromboplastin time (APTT) measures the integrity of the intrinsic (and common) pathways; and (6) every procoagulant step is balanced by a natural anticoagulant (antithrombin, protein C system, tissue factor pathway inhibitor). In the final analysis, hemostasis represents a balance between anticoagulant and procoagulant forces.15

Disorders in hemostasis occur when the hemostatic balance shifts toward one side or the other, resulting in one of two clinical phenotypes: bleeding or thrombosis. The myriad causes, diagnostic workup, and treatment of coagulation disorders are beyond the scope of this chapter. In the sections that follow, we consider the coagulopathy that occurs in patients with sepsis. The reasons for choosing sepsis as the case study are several-fold: (1) sepsis is common in the ICU and is responsible for most coagulation disorders; (2) a consideration of the mechanisms, diagnosis, and therapy of coagulopathy in this setting may be widely applicable to other conditions also associated with activation of the innate immune response (e.g., trauma, burns, postoperative systemic inflammatory response syndrome) and (3) recent therapeutic breakthroughs emphasize the importance of targeting the host response rather than the clotting cascade per se. In sepsis, hemostasis derangement is characterized by enhanced fibrin formation and dysfunction of the physiologic anticoagulant response, with depression of fibrinolysis and impaired fibrin removal.2,4

image Incidence

Previous studies demonstrated that the coagulation system is activated in virtually all patients with severe sepsis.24 In most such patients, activation may be minimal and detected only by test findings such as elevated circulating D-dimer levels,6 low protein C levels, or antithrombin deficiency.4,6 The activation also may be pronounced and characterized by the presence of thrombocytopenia or even disseminated intravascular coagulation (DIC), with evidence of both thrombosis and bleeding. It is estimated that DIC occurs in 15% to 30% of patients with severe sepsis or septic shock.2,4,7,8

image Mechanisms

In sepsis, the clotting cascade is initiated by tissue factor (TF). When TF is exposed to blood, it binds to factor VII. The complex TF-FVIIa activates factor X, which in turn forms a prothrombinase complex, leading to the generation of thrombin. Finally, thrombin converts fibrinogen into fibrin. TF is exposed to blood through either endothelial disruption or expression on the surface of circulating monocytes, tissue macrophages, and even endothelial cells.4,9,10

At the same time, sepsis attenuates all three physiologic anticoagulant mechanisms: activated protein C (APC), antithrombin (AT) and tissue factor pathway inhibitor (TFPI). APC has a key role in sepsis; along with protein S and thrombomodulin, it degrades factors V and VIII by a process accelerated by endothelial protein C receptors (EPCR). In sepsis, APC, protein S, thrombomodulin, and EPCR are down-regulated, rendering the system ineffective.11,12 AT is the main inhibitor of thrombin and factor Xa, whereas TFPI inhibits the TF-FVIIa complex. Levels of both AT and TFPI are markedly reduced in patients with sepsis.4,13,14 Sepsis also inhibits fibrinolysis.2,4 Together, these changes tilt the balance toward the procoagulant side, resulting in thrombin generation, fibrin deposition, and consumption of clotting factors and platelets. DIC represents the extreme case in this pathophysiologic continuum.24

Local activation of the coagulation system in sepsis is an integral component of the innate immune response and may play a protective role in walling off infection. However, in patients with severe sepsis, systemic activation of coagulation is harmful to the patient and associated with increased mortality.15 Other common forms of coagulopathy in the ICU are associated with severe trauma, massive blood losses, and shock. Recent studies suggest that early trauma-associated coagulopathy is triggered mainly by shock, mediated by activated protein C, and exacerbated by dilution of plasma and hypothermia.16,17 Interestingly, the early trauma-associated hypercoagulable state converts to a hypercoagulable one by 24 hours after trauma, carrying a higher risk of thrombotic complications.18 Other common coagulopathies in the ICU are caused by liver dysfunction, heparin and other anticoagulant medications, and vitamin K deficiency (Figures 21-1 and 21-2).

image Clinical Manifestations and Diagnosis

Buy Membership for Critical Care Medicine Category to continue reading. Learn more here